These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34870187)

  • 1. The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer.
    Santaolalla A; Hulsen T; Davis J; Ahmed HU; Moore CM; Punwani S; Attard G; McCartan N; Emberton M; Coolen A; Van Hemelrijck M
    Front Artif Intell; 2021; 4():769582. PubMed ID: 34870187
    [No Abstract]   [Full Text] [Related]  

  • 2. The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses.
    Marsden T; McCartan N; Brown L; Rodriguez-Justo M; Syer T; Brembilla G; Van Hemelrijck M; Coolen T; Attard G; Punwani S; Moore CM; Ahmed HU; Emberton M;
    PLoS One; 2022; 17(2):e0259672. PubMed ID: 35202397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.
    Green S; Tuck S; Long J; Green T; Green A; Ellis P; Haire A; Moss C; Cahill F; McCartan N; Brown L; Santaolalla A; Marsden T; Justo MR; Hadley J; Punwani S; Attard G; Ahmed H; Moore CM; Emberton M; Van Hemelrijck M
    Res Involv Engagem; 2021 Nov; 7(1):81. PubMed ID: 34789334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.
    Sood A; Kishan AU; Evans CP; Feng FY; Morgan TM; Murphy DG; Padhani AR; Pinto P; Van der Poel HG; Tilki D; Briganti A; Abdollah F
    Eur Urol Oncol; 2024 Feb; 7(1):27-43. PubMed ID: 37423774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI.
    Marsden T; Lomas DJ; McCartan N; Hadley J; Tuck S; Brown L; Haire A; Moss CL; Green S; Van Hemelrijck M; Coolen T; Santaolalla A; Isaac E; Brembilla G; Kopcke D; Giganti F; Sidhu H; Punwani S; Emberton M; Moore CM;
    BMJ Open; 2021 Sep; 11(9):e048144. PubMed ID: 34593491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy.
    Kelly BD; Ptasznik G; Roberts MJ; Doan P; Stricker P; Thompson J; Buteau J; Chen K; Alghazo O; O'Brien JS; Hofman MS; Frydenberg M; Lawrentschuk N; Lundon D; Murphy DG; Emmett L; Moon D
    Eur Urol Open Sci; 2023 Jul; 53():90-97. PubMed ID: 37441340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer.
    Van Poppel H; Hogenhout R; Albers P; van den Bergh RCN; Barentsz JO; Roobol MJ
    Eur Urol Oncol; 2021 Oct; 4(5):731-739. PubMed ID: 34364829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation.
    Mata LA; Retamero JA; Gupta RT; García Figueras R; Luna A
    Radiographics; 2021 Oct; 41(6):1676-1697. PubMed ID: 34597215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New markers in prostate cancer: Genomics.
    Fuessel S; Wirth MP
    Arch Esp Urol; 2019 Mar; 72(2):116-125. PubMed ID: 30855012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future direction of imaging in prostate cancer: MRI with or without contrast injection.
    Pecoraro M; Messina E; Bicchetti M; Carnicelli G; Del Monte M; Iorio B; La Torre G; Catalano C; Panebianco V
    Andrology; 2021 Sep; 9(5):1429-1443. PubMed ID: 33998173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
    Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
    Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic Resonance Imaging?
    Alberts AR; Schoots IG; Bokhorst LP; Drost FH; van Leenders GJ; Krestin GP; Dwarkasing RS; Barentsz JO; Schröder FH; Bangma CH; Roobol MJ
    Eur Urol; 2018 Mar; 73(3):343-350. PubMed ID: 28647216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
    Hendriks RJ; van der Leest MMG; Dijkstra S; Barentsz JO; Van Criekinge W; Hulsbergen-van de Kaa CA; Schalken JA; Mulders PFA; van Oort IM
    Prostate; 2017 Oct; 77(14):1401-1407. PubMed ID: 28853167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiogenomics influence on the future of prostate cancer risk stratification.
    Banerjee V; Wang S; Drescher M; Russell R; Siddiqui MM
    Ther Adv Urol; 2022; 14():17562872221125317. PubMed ID: 36160762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
    Ferro M; de Cobelli O; Vartolomei MD; Lucarelli G; Crocetto F; Barone B; Sciarra A; Del Giudice F; Muto M; Maggi M; Carrieri G; Busetto GM; Falagario U; Terracciano D; Cormio L; Musi G; Tataru OS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.